Manyanalystssay that Avandia is effectively a dead productafteran FDA advisorycommitteeagreed that itincreased the risk of heart attacksanddeathlast month.
"It doesn't take the pressure off the government, " Seema Desai, India analyst for the risk-advisory firm Eurasia Group, said of IKEA's investment proposal.